Clinical trial
Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for…
NCT00065728 · Alcon Research, Industry · Terminated
Key facts
| NCT number | NCT00065728 |
|---|---|
| Title | Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD |
| Official title | An Open Label Evaluation of Long Term Efficacy and Safety of Posterior Juxtascleral Injections of Anecortave Acetate 15 mg in Patients With Subfoveal Exudative Age-Related Macular Degeneration (AMD) |
| Lead sponsor | Alcon Research, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | Anecortave Acetate (AL-3789) Sterile Suspension, 30 mg/mL |
| Enrollment | 111 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Aug 1, 2003 |
| Last update posted | Sep 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: